Effects of Capros in Patients With Type-1 Diabetes

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 25, 2016

Study Completion Date

May 25, 2016

Conditions

Type I Diabetes

Interventions

DIETARY_SUPPLEMENT

Capros

250 mg BID

Trial Locations (3)

Carepoint East 543 Taylor Ave., Columbus

Martha Morehouse Medical Plaza 2050 Kenny Road, Columbus

Davis Heart and Lung Research Institute, Columbus

All Listed Sponsors

collaborator

Natreon, Inc.

INDUSTRY

lead

Ohio State University

OTHER

NCT02634216 - Effects of Capros in Patients With Type-1 Diabetes | Biotech Hunter | Biotech Hunter